Judy C. Arbique
MLT, ART(CSMLS), CLS(NCA),
BHSc
23 Braeside Lane
Halifax, NS, B3M 3J6
Telephone: (902) 445-4960
E-Mail: j.arbique@ns.sympatico.ca
RELEVANT SKILLS
AND EXPERIENCE (continued):
Publications/Presentations
• American Society of Microbiology conference (Orlando, FLA).
Poster Presentation: Evaluation of the Copan M40 and Starplex
Amies Transport Systems’ Potential to Prevent Overgrowth of
Aerobic Organisms During Simulated Transport (C-099) (May,
2006).
• American Society of Microbiology conference (Orlando, FLA).
Poster Presentation: Evaluation of the Copan M40 and Starplex
Amies Transport Systems’ Potential to Maintain the Viability of
Aerobic Fastidious Organisms During Simulated Transport (C-101)
(May, 2006).
• European Committee of Clinical Microbiology and Infectious
Disease (ECCMID) conference (Nice, France). Poster Presentation:
Evaluation of accuracy limits of countable colony-forming units
on agar plates (P-1725) (April, 2006).
• Maritech Conference 2004. Oral Presentation: Laboratory
Bioterrorism Preparedness (Nov 2004), Halifax, NS.
• Journal of Clinical Microbiology (Oct 2004)
(42(10):4686-4696).
Accuracy of Phenotypic and Genotypic Testing for Identification
of Streptococcus pneumoniae and Description of Streptococcus
pseudopneumoniae sp. nov.
• Nursing2003. (June 2003)(33(6):32hn1-32hn4).
Stop UTIs in their tracts.
• European Committee of Clinical Microbiology and Infectious
Disease (ECCMID) conference (Glasgow, Scotland). Poster
Presentation: Comparison of Methodologies for Anaerobic
Organisms Described in NCCLS Document M40-P, Quality Control of
Microbiological Transport Devices (P-652) (2003).
• American Society of Microbiology conference (Washington, DC).
Poster Presentation: Comparison of Methodologies Described in
NCCLS Document M40-P, Quality Control of Microbiological
Transport Devices (C-040) (2003).
• Prince Edward Island Society of Medical Laboratory Sciences
Conference (Charlottetown). Oral Presentation: Blood Collection
Updates (2002).
• Canadian Association of Clinical Microbiology and Infectious
Diseases Conference (Halifax). Poster Presentation: Early
Experience with 16S rRNA Gene Sequencing for the Identification
of Bacterial Pathogens (2002).
• Canadian Association of Clinical Microbiology and Infectious
Diseases Conference (Halifax). Oral Presentation: Validation of
Methodologies Described in NCCLS Document M40-P Quality Control
of Microbiological Transport Devices (2002).
• Pharmasave Atlantic Diabetes Conference (Dartmouth). Oral
Presentation: Point-of Care Testing (2002)
• Infection Control Association of Nova Scotia Conference
(Dartmouth). Oral Presentation: Asymptomatic Bacteriuria in the
Elderly Long-Term Care Resident (2002).
• Medical Laboratory Observer. “The
Community Phlebotomy Response Plan: How does your facility
measure up?” (July 2002).
• Phlebotomy Conference (Halifax). Oral Presentations: Blood
Collection Updates and Blood Culture Collection (2002).
• Canadian Society of Medical Laboratory Sciences Conference
(Saint John’s, Nfld.). Oral Presentation: Asymptomatic
bacteriuria in the elderly long-term-care resident (June 2001).
• New Brunswick Society of Medical Laboratory Technologists
Technical Days (Saint John, N.B.). Oral Presentation: MRSA
Roundtable Discussion (May 2001).
• Journal of Diagnostic Microbiology and Infectious Disease.
“Comparison of the Velogene Rapid MRSA Identification Assay,
Denka MRSA-Screen Assay, BBL Crystal MRSA ID System, and PCR for
rapid identification of methicillin-resistance in Staphylococcus
aureus” (July 2001).
• 40th Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC), Toronto. Poster Session: “The Activity of
BMS-284756, a Novel DES-(6)F-Quinolone, Against Ciprofloxacin
Susceptible and Non-susceptible Streptococcus pneumoniae.”
(2000).
• 40th Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC), Toronto. Poster Session: (Levofloxacin
treatment failure of pneumococcal pneumonia and development of
resistance during therapy. (2000).
• Journal of Diagnostic Microbiology and Infectious Disease.
“Intra and inter technologist variability in the quality
assessment of respiratory tract specimens.” (August 2000).
• American Society of Microbiology Conference (Los Angeles).
Poster session: Erythromycin and clindamycin resistance in
isolates of Group A Streptococcus (GAS) in Halifax (May, 2000).
• American Society of Microbiology Conference (Los Angeles).
Poster session: Comparison of the Velogene Rapid MRSA
Identification Assay, Denka MRSA-Screen Assay, BBL Crystal MRSA
ID System, and PCR for rapid identification of methicillin-resistance
in Staphylococcus aureus (May, 2000).
• Journal of Diagnostic Microbiology and Infectious Disease.
“Evaluation of four commercial transport media for the survival
of Neisseria gonorrhoeae” (March, 2000).
• Canadian Association of Clinical Microbiology and Infectious
Diseases Conference (Edmonton). Poster session: Erythromycin and
clindamycin resistance in pharyngeal isolates of Group A
Streptococcus (GAS) in Halifax (Nov 1999).
• Journal of Infection Control. “Cumulative Yield of
Surveillance Cultures in a Hospital Out-break of MRSA.” (1997).
• Canadian Journal of Medical Technology. “Take Control of
Quality!” (1994).
Publication
Links:
Selection # 1
Selection # 2
Selection # 3
Selection # 4
Selection # 5
Selection # 6
NEXT
